NCT00005232View on ClinicalTrials.gov

Gubbio Study Five-year Follow-up: Lithium Countertransport, Blood Pressure, and Other Variables

CompletedOBSERVATIONAL
Timeline

Start Date

August 31, 1988

Study Completion Date

July 31, 1993

Conditions
Cardiovascular DiseasesHeart DiseasesHypertensionCoronary Disease
All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00005232 - Gubbio Study Five-year Follow-up: Lithium Countertransport, Blood Pressure, and Other Variables | Biotech Hunter | Biotech Hunter